Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sharon M. Sagnella"'
Autor:
Gerard J. Chu, Charles G. Bailey, Rajini Nagarajah, Sharon M. Sagnella, Stephen Adelstein, John E. J. Rasko
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-18 (2023)
Abstract Background Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD19- and B-cell maturation antigen-positive haematological malignancies. However, the effect of a CAR construct on the function of T-cells stimulated vi
Externí odkaz:
https://doaj.org/article/c567b9f811a84470a0eab063b6a318d5
Autor:
Sharon M, Sagnella, Amy L, White, Dannel, Yeo, Payal, Saxena, Nico, van Zandwijk, John E J, Rasko
Publikováno v:
Pharmacological Research. 182:106329
Cellular therapies utilizing T cells expressing chimeric antigen receptors (CARs) have garnered significant interest due to their clinical success in hematological malignancies. Unfortunately, this success has not been replicated in solid tumors, wit
Autor:
Maria Kavallaris, Xiaoyu Cheng, Stuart B. Lowe, J. Justin Gooding, Xin Chen, Xun Lu, Jason Scott, Alexander H. Soeriyadi, Sharon M. Sagnella
Publikováno v:
Biomaterials science. 2(1)
A silica-based mesoporous nanosphere (MSN) controlled-release drug delivery system has been synthesized and characterized. The system uses L-cysteine derivatized gold nanoparticles (AuNPs), bound to the MSNs using Cu2+ as a bridging ion. The AuNPs se
Autor:
John A. Boockvar, Ebru Boslem, Natasha Vanegas, Gemma E. Stubbs, Katarzyna Smolarczyk, Stephen Clarke, Jennifer A. MacDiarmid, Eva St. Clair, Sharon M. Sagnella, Lu Yang, Himanshu Brahmbhatt, Stacey L. Pattison, Estefania Martino-Echarri
Publikováno v:
Cancer cell. 37(3)
Summary Immunotherapy has emerged as a powerful new chapter in the fight against cancer. However, it has yet to reach its full potential due in part to the complexity of the cancer immune response. We demonstrate that tumor-targeting EDV nanocells fu
Autor:
Jennifer Trieu, Andrew J. Gifford, Joshua A. McCarroll, Sharon M. Sagnella, Jennifer A. MacDiarmid, Christopher M. Fife, Renee Whan, David S. Ziegler, Maria Kavallaris, Himanshu Brahmbhatt, Alexander Macmillan
Publikováno v:
Molecular cancer therapeutics. 17(5)
Advanced stage neuroblastoma is an aggressive disease with limited treatment options for patients with drug-resistant tumors. Targeted delivery of chemotherapy for pediatric cancers offers promise to improve treatment efficacy and reduce toxicity ass
Autor:
Alexander H. Soeriyadi, Xun Lu, Sharon M. Sagnella, Maria Kavallaris, Xin Chen, J. Justin Gooding
Publikováno v:
Advanced Functional Materials. 24:6999-7006
Despite the rapid development of drug delivery vehicles that react to a specific biological environment, the complexity of triggering drug release in a particular target area remains an enduring challenge. Here, the engineering of bioresponsive polym
Autor:
Maria Kavallaris, Christopher M. Fife, Jonathan P. Wojciechowski, Alexander F. Mason, Pall Thordarson, Sharon M. Sagnella, Adam D. Martin
Publikováno v:
ChemPlusChem. 82(3)
Two peptide-derived low-molecular-weight gelators bearing different capping groups, 9-fluorenylmethyloxycarbonyl (Fmoc) and phenothiazine, were synthesized and their gel networks were characterized. The variation of the N-terminal capping group affec
Autor:
Joshua A. McCarroll, Phoebe A. Phillips, David Goldstein, George Sharbeen, Cyrille Boyer, Thomas P. Davis, Maria Kavallaris, Hien T. T. Duong, Joann Teo, Jie Liu, Janet Youkhana, Sharon M. Sagnella
Publikováno v:
Biomacromolecules. 17(7)
Pancreatic cancer is a devastating disease with a dismal prognosis. Short-interfering RNA (siRNA)-based therapeutics hold promise for the treatment of cancer. However, development of efficient and safe delivery vehicles for siRNA remains a challenge.
Autor:
Minoo J. Moghaddam, Xiaojuan Gong, Lynne J. Waddington, Charlotte E. Conn, Calum J. Drummond, Sharon M. Sagnella, Stephen J. Danon
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 85:349-359
An amphiphile prodrug, 5'-deoxy-5-fluoro-N(4)-(palmityloxycarbonyl) cytidine or 5'-deoxy-5-fluoro-N(4)-(hexadecanaloxycarbonyl) cytidine (5-FCPal), consisting of the same head group as the commercially available chemotherapeutic agent Capecitabine, l
Autor:
Lynne J. Waddington, Charlotte E. Conn, Xavier Mulet, Nigel Kirby, Minoo J. Moghaddam, Sharon M. Sagnella, Calum J. Drummond, Joseph N. Varghese, Connie Darmanin
Publikováno v:
Soft Matter. 7:567-578
Intrinsic difficulties in characterizing the structure of combined membrane protein–lyotropic liquid crystalline lipidic cubic systems have hampered the development of techniques such as membrane protein (MP) crystallization, which remain largely e